Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: Results from a phase 2a proof-of-concept study

J Am Acad Dermatol. 2022 Nov;87(5):1189-1191. doi: 10.1016/j.jaad.2022.02.060. Epub 2022 Mar 7.
No abstract available

Keywords: congenital ichthyosis; isotretinoin; retinoids; scaling; topical therapy.

Publication types

  • Clinical Trial, Phase II
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Humans
  • Ichthyosiform Erythroderma, Congenital*
  • Ichthyosis, Lamellar*
  • Isotretinoin / adverse effects

Substances

  • Isotretinoin